卡爾維斯塔製藥公司
US ˙ NasdaqGM ˙ US4834971032

SecurityKALV / KalVista Pharmaceuticals, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership515,650 shares
Latest Disclosed Value $ 10,380,034
UBS Group AG reports 38.62% increase in ownership of KALV / KalVista Pharmaceuticals, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 515,650 shares of KalVista Pharmaceuticals, Inc. (US:KALV) valued at $10,380,034 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 371,993 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of 38.62% during the quarter. The current value of the position is $13,896,768 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 515,650 143,657 38.62 10,380 72.80 0.0003
2026-01-29 2025-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 371,993 -82,155 -18.09 6,008 8.61 0.0002
2025-11-13 2025-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 454,148 181,287 66.44 5,532 79.35 0.0009
2025-08-14 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 272,861 -234,842 -46.26 3,085 -47.35 0.0005
2025-05-13 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 507,703 133,072 35.52 5,859 84.62 0.0011
2025-02-14 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 374,631 331,202 762.63 3,173 532.07 0.0006
2024-11-14 2024-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 43,429 30,023 223.95 503 219.75 0.0001
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 13,406 -15,111 -52.99 158 -53.55 0.0000
2024-05-13 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 28,517 1,413 5.21 338 1.81 0.0001
2024-02-09 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 27,104 4,838 21.73 332 55.14 0.0001
2023-11-09 2023-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 22,266 6,397 40.31 214 50.70 0.0001
2023-08-11 2023-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 15,869 9,123 135.24 143 167.92 0.0000
2023-05-12 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 6,746 -2,888 -29.98 53 -18.46 0.0000
2023-02-08 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 9,634 8,402 681.98 65 261.11 0.0000
2022-11-10 2022-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 1,232 168 15.79 18 80.00 0.0000
2022-08-10 2022-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 1,064 -41,929 -97.53 10 -98.42 0.0000
2022-05-16 2022-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 42,993 -10,570 -19.73 634 -10.45 0.0002
2022-02-14 2021-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 53,563 20,335 61.20 708 22.07 0.0002
2021-11-15 2021-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 33,228 28,906 668.81 580 457.69 0.0002
2021-08-13 2021-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 4,322 -6,454 -59.89 104 -62.45 0.0000
2021-05-12 2021-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 10,776 9,007 509.16 277 714.71 0.0001
2021-02-11 2020-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 1,769 1,011 133.38 34 240.00 0.0000
2020-11-12 2020-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 758 -3,557 -82.43 10 -80.77 0.0000
2020-07-31 2020-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 4,315 -3,196 -42.55 52 -8.77 0.0000
2020-05-01 2020-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 7,511 -9,882 -56.82 57 -81.61 0.0000
2020-02-14 2019-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 17,393 6,682 62.38 310 150.00 0.0001
2019-11-14 2019-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 10,711 8,605 408.59 124 163.83 0.0000
2019-08-14 2019-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 2,106 1,621 334.23 47 235.71 0.0000
2019-05-14 2019-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 485 485 14 0.0000
2019-02-14 2018-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -660 -100.00 0 -100.00
2018-11-14 2018-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 660 -2,454 -78.81 14 -44.00 0.0000
2018-08-14 2018-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 3,114 2,969 2,047.59 25 2,400.00 0.0000
2018-05-15 2018-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 145 -1,446 -90.89 1 -93.75 0.0000
2018-02-14 2017-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 1,591 1,591 16 0.0000
2017-11-14 2017-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -1,506 -100.00 0 -100.00
2017-11-14 2017-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 1,506 -801 -34.72 11 -38.89 0.0000
2017-08-14 2017-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 1,506 -801 11
2017-11-14 2017-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 2,307 1,398 153.80 18 200.00 0.0000
2017-05-12 2017-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 2,307 1,398 18
2017-02-14 2016-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 909 909 6 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.